Board of Directors

Dr. Scott Wolf is a prolific medical device entrepreneur with a long history of developing aesthetic medicine therapies. Scott is the founder of Zeltiq Aesthetics, the maker of CoolSculpting, the leading non-invasive method of fat reduction for bodysculpting.  Zeltiq was acquired by Allergan for $2.5B. Scott was also a board observer with Kythera, which developed Kybella, an injectable compound for fat removal. Kythera was also acquired by Allergan for $2B. Scott is also the founder of Aerin Medical which developed a non-surgical therapy for patients with nasal obstruction. Scott was a partner at Prospect Venture Partners and a vice-president at Frazier Healthcare Ventures, both leading life science venture capital firms. Scott received his M.D. from George Washington University and his B.A. from the University of Pennsylvania.

Richard J. Prati, a seasoned business executive, investor, entrepreneur, philanthropist, and hands-on turnaround specialist, has served as Chief Executive Officer of Life Care Medical Devices since November 2013 (www.lcmd.com), and CEO of Prati Management, a Family Office since 2012.  Richard has 25 years of proven financial leadership and operational execution in investment banking, institutional equity sales, and professional investment management. As a Principal at several notable Wall Street investment firms, Mr. Prati has a strong history of exceptional value creation and a successful track record of transformational, business turnaround expertise including sourcing and executing transactions, accessing the public and private markets and catalyzing sizable revenue growth production. He has guided a wide range of emerging and established public and private entities in industries ranging from healthcare, biotech, medical devices, conglomerates, retail, industrials, information technology and semiconductors companies.

Mr. Prati Co-Founded, a young medical technology start-up, Singular Medical Technologies, Inc. (http://singmedtech.com/), and serves as Chairman. Singular addresses in a unique and innovative way the global problem of PACS incompatibility and hospital consolidation. Mr. Prati also recently served as Vice Chairman of PVG Asset Management (www.pvgassetmanagement.com), a fund family with nearly $1 Billion in assets for three years, and is a board member and early-stage investor of the privately-held Centennial Brands company. In 2002 Mr. Prati was one of two co-founders of American Technology Research (AmTech), an independent research broker/dealer and negotiated the $35 million sale of AmTech to Broadpoint in 2008. He then served as President and Vice Chairman of the equities division of Gleacher and Company (GLCH, which merged with Broadpoint AmTech shortly after the acquisition of AmTech). In 2010, Mr. Prati accepted the position Senior Managing Director of Equities at Sterne Agee, a large regional brokerage-firm that was recently acquired by Stifel Nicolaus. Prior to founding AmTech, Mr. Prati was a Senior Partner at SoundView Technology Group, ran the west coast and launched the Denver office as well as establishing firm records as the top revenue producer his final three years. Richard served as an Executive Director at SG Warburg (UBS) in institutional equity sales, after embarking on his successful Wall Street career as an investment banker at Dean Witter Reynolds (acquired by Morgan Stanley). He earned his MBA from the William E. Simon Graduate School of Business Administration at the University of Rochester and his B.S in Economics from Vanderbilt University.

Dr. Timothy I. Cohen, Member, Board of Directors. Dr. Timothy Cohen is a neurosurgeon in Anchorage, Alaska and is affiliated with multiple hospitals in the area, including Alaska Regional Hospital and Providence Alaska Medical Center. He earned his medical degree from University of Virginia School of Medicine and has been in practice for more than 20 years. Dr. Cohen received his board certification through the American Board of Neurological Surgery and completed his Fellowship in Reconstructive & complex spine surgery at the University of New Mexico, Albuquerque, NM and his Residency Training at University of North Carolina - Chapel Hill, Division of Neurosurgery - Chapel Hill, NC. Dr. Cohen's expertise includes: disc replacement, degenerative, traumatic & neoplastic diseases of the spine as well as treatment of brain tumors including pituitary adenomas.

Nickolay Kukekov, Ph.D. is a co-founder and a principle at Highline Research Advisors, which is an affiliate of Merriman Capital Inc. Highline is a full service investment bank which assists emerging healthcare companies with raising capital, M&A, strategic advisory and IPOs. Prior to building Highline, Dr. Kukekov was a Managing Director of Healthcare Investment Banking at Summer Street Research and, prior to that, was a managing director at Paramount BioCapital, where he ran the advisory and M&A services for in-house private and public portfolio companies. Before that, he was a senior healthcare investment banker at Rodman & Renshaw. Dr. Kukekov's scientific background includes a bachelor degree in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder and a Ph.D. in Neuroscience from Columbia University, College of Physicians and Surgeons in New York. Dr. Kukekov holds a number of research scholarship awards and peer review publications.

Trevor A. Moss is a seasoned senior executive and company director with extensive international experience in the international natural resources industries and holds a base of experience extending from major resource companies to emerging juniors and including international corporate development and project engineering and construction companies. During his career Mr. Moss has gained direct experience in the full range of corporate activities from managing public and private companies, through the raising of equity and debt capital, corporate mergers, asset acquisitions and sales, to government relations and project management for the development, startup and commercial operation of new and retrofit projects. With expertise in financial and contractual management combined with strong technical acumen Mr. Moss possesses an enviably deep skills base essential for successful company and project development. Mr. Moss is adept in delivering shareholder value and as part of the Executive management team at Nevsun Resources was directly responsible for development activities that lead to a +15-fold increase in share price over a 2½–year period.

Throughout his extensive career Mr. Moss has engaged in grass roots development, ‘brown field’ redevelopment, and the operation of companies and projects in a wide variety of international and domestic locations. Specific industries served include mining, infrastructure, energy, chemical and construction.

Mr. Moss has gained a wealth of experience through senior roles within large corporations, such as Cyprus Amax Minerals, Newmont, Barrick Gold and Aker Kvaerner, and from comprehensive executive management and board duties within emerging junior resource companies including Nevsun Resources.

Most recently Mr. Moss has been providing independent executive management services directed toward a broad range of development opportunities for a variety of international companies. Acting as a corporate executive and company director most recently Mr. Moss has held decision level responsibility for mining development projects in eastern Africa, South America, Vietnam, Eastern Europe and North America and energy and IPP project development in Africa and North America.

Dr. Camran Nezhat has been called the father of modern-day operative laparoscopy for introducing the technique of video-assisted endoscopy.1-3 Along with his brothers, Drs. Farr and Ceana Nezhat, and their teams, he performed some of the most advanced pathologies endoscopically for the first time. Thus, opened up the path and the landscape for endoscopic surgeons all over the world.1-41

Some of these procedures included: laparoscopic treatment of extensive endometriosis,4,5 bowel resection (including shaving technique, disk excision, segmental colon resection by natural orifice of vagina and rectum, also by mini laparotomy and total laparoscopy),6-17 bladder resection,18 ureter resection,19-21 diaphragm resection and reanastamosis22, radical hysterectomy with paraaortic and pelvic node dissection,15,16,23,24 management of ovarian remnant,25 laparoscopic-assisted myomectomy,26 sacral colpopexy,15,27 laparoscopic repair of vesico vaginal fistulas,28 operative laparoscopy during advanced pregnancy29, vaginal cuff dehiscence following laparoscopic hysterectomy,30 laparoscopic repair of major retroperitoneal vessels,31,32 laparoscopic repair of Cesarean section defect (Niche procedure),33 laparoscopic debulking for advanced ovarian cancer,34 laparoscopic treatment of liver endometriosis,35 and laparoscopic treatment of lung endometriosis.36,37 Drs. Nezhat also proposed a new classification for ovarian endometriomas, based on the pathological findings.38 These were all among some of the procedures performed endoscopically, for the first time, by Camran Nezhat, M.D. and his team.

Camran Nezhat, M.D. collaborated with robotic pioneers, Ajit Shah and Phil Green, in the 1990’s, for the development of the da Vinci Robot.

He is author of eight textbooks and several hundred articles, and has trained many physicians, who have become pillars of their communities, internationally.

He lives and practices medicine in the San Francisco Bay Area.

  1. Podratz, Karl, MD PHD. Degrees of Freedom: Advances in Gynecological and Obstetrical Surgery. Remembering Milestones and Achievements in Surgery: Inspiring Quality for a Hundred Years 1913--‐2012. Published by American College of Surgeons 2012. Tampa: Faircount Media Group; 2013.
  2. Carter JE. Biography of Camran Nezhat, MD, FACOG, FACS. JSLS: Journal of the Society of Laparoendoscopic Surgeons. 2006;10 (2):275-­‐280.
  3. Kelley WE. The Evolution of Laparoscopy and the Revolution in Surgery in the Decade of the 1990s. JSLS: Journal of the Society of Laparoendoscopic Surgeons. 2008;12(4):351-­‐357.
  4. Nezhat C. Laser laparoscopy for the treatment of endometriosis. Paper presented at: Conjoint Meeting of the American Society for Reproductive Medicine and the Canadian Fertility and Andrology Society; 1985; Toronto, Canada
  5. Nezhat, C., Crowgey, S. R. & Garrison, C. P. Surgical treatment of endometriosis via laser laparoscopy. Fertility & Sterility. P 45, 778 -­‐ 783. (1986)
  6. Nezhat C, Nezhat F. Evaluation of safety of videolaseroscopic treatment of bowel endometriosis, Scientific Paper, 44th Annual Meeting of the American Fertility Society, Atlanta Hilton and Towers, Atlanta, Georgia, October 8 ­‐- 13, 1988
  7. Nezhat CR, Nezhat FR. Safe laser excision and vaporization of endometriosis. Fertil Steril, 1989; P 52(1): 149 – 151
  8. Nezhat C, Pennington E, Nezhat F, Silfen SL. Laparoscopically assisted anterior rectal wall resection and reanastomosis for deeply infiltrating endometriosis. Surg Laparosc Endosc, June 1991;1(2): 106 ­‐- 108.
  9. Nezhat F, Nezhat C, Pennington E. Laparoscopic proctectomy for infiltrating endometriosis of the rectum. Fertil Steril, May 1992;57(5): 1129 -­‐ 1132.
  10. Nezhat F, Nezaht C, Pennington E, Ambroze W Jr. Laparoscopic segmental resection for infiltrating endometriosis of the recto sigmoid colon: a preliminary report, Surg Laparosc Endoc. 1992;2:212-216
  11. Nezhat C, Nezhat F, Pennington E. Laparoscopic treatment of lower colorectal and infiltrating rectovaginal septum endometriosis by the technique of videolaserooscopy. Br J Obstet Gynae- col. 1992;99:664-667
  12. Nezhat C, Nezhat F, Nezhat CH. Surgery for Endometriosis of the Bowel, Bladder, Ureter, and Diaphragm. Annals of the New York Academy of Sciences, 1997; 828: 332-340
  13. Nezhat C, Nezhat F, Pennington E, et al. Laparoscopic disk excision and primary repair of the anterior rectal wall for the treatment of full thickness bowel endometriosis, Surg Endosc. 1994;8:682-685
  14. Nezhat C, Nezhat F, Ambroze W. & Pennington E, Laparoscopic repair of small bowel and colon: A report of 26 causes. Surg Endosc. P 7(2): 88-89, (1993)
  15. Nezhat, C, Nezhat F, Nezhat C, Operative laparoscopy (minimally invasive surgery). State of the art, J Gynecol Surg. 1992; 8:111-141.
  16. Nezhat C, Nezhat F. Stilfen SL, Videolaseroscopy: the CO2 laser for advanced operative laparoscopy. Obstet Gynecol Clin North Am. 1991; 18:585-604
  17. Nezhat F. Triumphs and controversies in laparoscopy: the past, the present, and the future. JSLS, 2003; 7:1 – 5.
  18. Nezhat C, Nezhat F. Laparoscopic segmental bladder resection for endometriosis: a report of two cases. Obstet Gynecol. 1993;81:882-884
  19. Nezhat C, Nezhat F, Green B. Laparoscopic treatment of obstructed ureter due to endometriosis by resection and ureteroureterostomy. A case report. J Urol. 1992; 148:865-868.
  20. Nezhat CH, Malik S, Nezhat F, Nezhat C. Laparoscopic ureteroneocystostomy and vesicopsoas hitch for infiltrative endometeriosis, 2004; 8:3-7.
  21. Nezhat CH, Nezhat F, freiha F, Nezhat C. Laparoscpic vesicopsoas hitch for infiltrative ureteral endometriosis. Fertil Steril. 1999;71:376-379.
  22. Nezhat F, Nezhat C, Levy JS. Laparoscopic treatment of symptomatic diaphragmatic endometriosis: A case report. Fertil Steril. 1992;58:614-616.
  23. Nezhat C, Burrell M, Nezhat F, Benigno B, Welander CE. Laparoscopic radical hysterectomy with paraaortic and pelvic node dissection. Am J Obstet Gynecol. 1992; 166:864-865.
  24. Nezhat CR, Nezhat FR, Ramirez CE, et al. Laparoscopic radical hysterectomy and laparoscopic assisted vaginal radical hysterectomy with pelvic and paraaortic node dissection, J Gynecol Surg. 1993; 9:105-120.
  25. Nezhat F, Nezhat C. Operative laparoscopy for the treatment of ovarian remnant syndrome. Fertil Steril, May 1992;57(5): 1003 – 1007.
  26. Nezhat C, Nezhat F, Bess O, Nezhat CH, Mashiach R. Laparoscopically assisted myomectomy: a report of a new technique in 57 cases, Intl J Fertil Menopausal Stud. P 39(1): 39 – 44. (1994)
  27. Nezhat F, Nezhat C, Nezhat CH. Laparoscopic sacral colpopexy for vaginal wall prolapse. Obstet Gynecol. 1994;84:885 – 888.
  28. Nezhat CH, Nezhat F, Nezhat C, Rottenberg H. Laparoscopic repair of a vesicovaginal fistula: a case report. Obstet Gynecol. 1994;883:889 -901.
  29. Nezhat F, Nezhat C, Silfen S, Fehnel S. Laparoscopic treatment of ovarian cyst during pregnancy. J Laparoendosc Surg. 1991;1:161-164.
  30. Nezhat CH, Nezhat F, Seidman DS, Nezhat C. Vaginal vault evisceration after total laparoscopic hysterectomy. Obstet Gynecol 1996;87 : 868 – 870.
  31. Nezhat C, Childers J, Nezhat F, et al. Major retroperitoneal vascular injury during laparoscopic surgery. Hum Reprod. 1997 ; 12:480 – 483.
  32. Jacobson M, Oesterling S, Milki A, Nezhat CR. Laparoscopic control of a leaking inferior mesenteric vessel secondary to trocar injury. JSLS. 2002;6:389-391.
  33. Jacobson M, Osias J, Velasco A, Charles R, Nezhat C. Laparoscopic repair of a uteroperitoneal fistula. 2003;7:367-369.
  34. Amara DP, Nezhat C, Teng NN, Nezhat C, Rosati M. Operative laparoscopy in the management of ovarian cancer. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. P 6(1):38 – 45. (1996)
  35. Nezhat C, Kaerooni T, Berker B, LaShay N, Susan Fernan- dez S, Marziali M. Laparoscopic management of hepatic endometriosis: report of Two Cases and review of literature. J Min Invas Gynecol. 2005;12:196-200.
  36. Nezhat C, King LP, Paka C, Odegaard J, Beygui R. Bilateral thoratic endometriosis affecting the lung and diaphragm. JSLS : Journal of the Society of Laparoendoscopic Surgeons. P 6:140 – 142. (2012)
  37. Nezhat C, Main J, Paka C, Nezhat A, Beygui R. Multidisciplinary Treatment for Thoracic and Abdominopelvic Endometriosis. Journal of the Society of Laparoendoscopic Surgeons. Vol 18, Issue 3, July-Sept. (2014)
  38. Nezhat F, Nezhat C, Allan CJ, Metzger DA, Sears DL. Clinical and histologic classification of endometriomas: implications for a mechanism of pathogenesis. J Repro Med. 1992;37:771-776
  39. Nezhat C, My Journey with AAGL. Journal of Minimally Invasive Gynecology. 2010; 17(3): 271-277.
  40. Nezhat C. Operative endoscopy will replace almost all open procedures. JSLS. 2004;8:101-102.
  41. Nezhat C. 2005 Presidential address. JSLS 2005; 9:370-375.

Some other early reports, by Drs. Camran, Farr, and Ceana Nezhat, in peer reviewed journals:

  1. Nezhat C, Winer WK, Nezhat F. Laparoscopic removal of dermoid cysts. Obstet Gynecol, February 1989;73(2): 278 -- 281.
  2. Nezhat F, Winer WK, Nezhat, C. Fimbrioscopy and salpingoscopy in patients with minimal to moderate pelvic endometriosis. Obstetrics and Gynecology. P 75(1): 15 – 17. (1990)
  3. Nezhat F, Nezhat C, Gordon S, Wilkins E. Laparoscopic versus abdominal hysterectomy. J Reprod Med, March 1992;37(3):247 – 250.
  4. Nezhat C, Nezhat F, Burrell M. Laparoscopically assisted hysterectomy for the management of borderline ovarian tumor: A case report. J Laparoendosc Surg, Aug 1992; 2(4): 167 -169
  5. Nezhat C, Lavie O, Lemyre M, Gemer O, Bhagan L, Nezhat CH. Laparoscopic hysterectomy with and without a robot: Stanford experience. JSLS. P 13(2): 125 – 128. (2009)
  6. Nazhat C, Lavie O, Hsu S, Watson J, Barnett O, Lemyre M. Robotic-assisted laparoscopic myomectomy compared with standard laparoscopic myomectomy – a retrospective matched control study. Fertility and Sterility Vol. 91 (2), p 556 – 565. (2009)
  7. Nezhat C, Lavie O, Lemyre M, Unal E, Nezhat CH, Nezhat FR, Robotic-Assisted Laparoscopic Surgery in Gynecology: Scientific Dream or Reality? Fertility and Sterility, Volume 91, Issue 6, P 2620 – 2622, (2008).
  8. Nezhat C, Saberi NS, Shahmohamady B, Nezhat F. Robotic-assisted laparoscopy in gynecological surgery JSLS. Vol 10 (3), p 317 – 320. (206)
  9. Nezhat C, Hajhosseini B, King LP. Robotic-assisted laparoscopic treatment of bowel, bladder, and ureteral endometriosis. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons. P 15: 387 – 392. (2011)

Dr. Farr Nezhat is a Board Certified Gynecologic Oncologist. He is a world-renowned authority in advanced laparoscopic and robotic surgery for the treatment of gynecological cancers and complex benign conditions such as uterine fibroids, pelvic masses and severe and multi-organ endometriosis.

He devoted his early career as a gynecologist to pioneering advanced laparoscopic surgical techniques for treating extensive pelvic endometriosis. He addressed endometriosis involving other pelvic organs such as the bowel, bladder, ureter and even the diaphragm, by forming a multi-disciplinary approach. Dr. Nezhat concentrated on treatment of other pelvic pathology and contributed numerous surgical “firsts” to the literature, establishing evidence-based protocols for improved patient care.

One of his main interests is the laparoscopic management of ovarian cysts and masses. He demonstrated the ability to manage adnexal masses by laparoscope instead of by laparotomy, and this has had a profound medical and societal impact.

Recognizing the potential impact of minimally invasive surgery in the treatment of gynecologic cancer, Dr. Nezhat completed a fellowship in gynecologic gynecology. Subsequently, he was able to refine and develop laparoscopic operative techniques for efficient, safe and efficacious application to gynecological oncology. His work resulted in several groundbreaking publications on laparoscopic and robotic management of cervical, endometrial and ovarian cancer. During his fellowship, and growing from his experience with endometriosis, he developed an interest in cancer arising from endometriosis, resulting in widely recognized, influential studies.

Dr. Nezhat established a minimally invasive surgery division and fellowships at three hospitals, thereby providing training opportunities for vast numbers of fellows, residents, medical students and national and international visiting physicians. He was one of the first to perform, publish and teach robotic surgery in gynecology.

He contributes prolifically to the scientific and medical literature, having authored four textbooks on operative laparoscopy, robotics and hysteroscopy and one on medical and surgical management of endometriosis, and dozens of book chapters.

He organizes frequent post-graduate courses, which include didactic lectures, hands-on training simulations, and live surgery demonstrations. He has performed live surgery upon invitation in many countries as part of his charitable teaching endeavors.

Dr. Nezhat continues to research and publish in the areas of the pathophysiology of ovarian cancer, malignant transformation of endometriosis, and application of laparoscopy and robotics in gynecological malignancy, specifically in early and advanced ovarian cancer.

He is a regularly invited faculty member at numerous national and international professional societies and congresses, having visited over 30 countries. He believes learning, training, and collaboration are inseparable foundational components for the most meaningful breakthroughs.

Historically, ovarian cancer and endometriosis have had significant negative consequences. Dr. Nezhat’s work has benefitted countless women and their families worldwide.

Mr. Pichon just retired at the end of 2016 and managed $1.5 billion in assets for his Anchorage based money management firm. An Investment Advisor Representative who recently wrapped up his Wall Street career at Wells Fargo Advisors, LLC in Anchorage, AK with over 33 years of experience in the finance industry. Wayne Pichon has taken additional exams to become a Certified Financial Planner (CFP(r)). B.S. in Education, Eastern Illinois University, Charleston, IL, 1968. M.S. in Botany, Eastern Illinois University, Charleston, IL, 1972. CFP, College of Financial Planning, Greenwood Village, CO, 1988.